Pharma News

Sun Pharmaceutical Industries Ltd. has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec®, Imatinib Mesylate tablets 100mg and 400mg. Gleevec® is the registered trademark of Novartis Pharmaceuticals Corporation.

Cipla Ltd, a global pharmaceutical company announced that it has launched a novel “5 in 1” anti-ageing skin care product Cutisera developed by Stempeutics. Cutisera has been developed using bio-active factors derived from human adult stem cells to enhance the rejuvenation of ageing skin.

Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced that the European Medicines Agency (EMA) granted Orphan Drug Designation for ADXS-HER2 for the treatment of osteosarcoma.

Biotronik, the world’s leading manufacturer of MR conditional cardiac devices, has announced that its Eluna 8 pacemaker is now available in Japan. The pacemaker is approved for 1.5 tesla (T) full-body MRI scans, and ultra-high strength 3.0 T MRI scans with an exclusion zone.

AbbVie, a global biopharmaceutical company, announced its New Drug Application (NDA) has been accepted by the U.S. Food and Drug Administration (FDA) for a once-daily, fixed-dose formulation of the components of VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets). VIEKIRA PAK is an all-oral, interferon-free treatment approved with or without ribavirin (RBV) in the United States for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated cirrhosis. VIEKIRA PAK is not for people with decompensated cirrhosis.

Chinese doctors have cured a patient of leukemia using gene therapy, a hospital in Chongqing announce. Zhang Fang, a middle-aged woman, has been cured of leukemia after she was treated with CAR T therapy, Xinhua reported.

If you are planning a baby, do not just sermon your wife to eat well but control your diet first. According to a fascinating study, sperm carries key information about what new dads gulped down before the conception.

Researchers have identified a biomarker that detects the most common lung cancer in its earliest stage.

In order to bring interventions from various backgrounds under a single umbrella, a group of top neurosurgeons has come together to form India's first dedicated society for therapeutic neurointerventions.

Scientists at the Centre for DNA Fingerprinting and Diagnostics (CDFD) have discovered a novel protein which could lead to development of a therapy for tuberculosis.